Project Grant HT94252510261
Award Date
5/1/25
Completion Date
4/30/29
Dollars Obligated
$906K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
The U.S. Defense Health Agency awarded a $2,728,777 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Rector & Visitors of the University of Virginia (UVA) to conduct research on "Neuroactive Steroid Biosynthesis and Dynamic GABAA Receptor Reconfiguration in Postpartum Depression". The 4-year grant, which began on May 1, 2025 and runs through April 30, 2029, will enable UVA to carry out cutting-edge biomedical research aimed at...
The U.S. Department of Defense's Defense Health Agency awarded a $323,538 Project Grant to The Johns Hopkins University to conduct research on "The Role of Autophagy in the Etiology of Postpartum Depression." This grant, provided under the Military Medical Research and Development CFDA program (12.420), supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative and impactful research. The funding...
This $3,028,589.00 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Dionysus Digital Health Inc., a self-certified small disadvantaged business, for a project titled "PPD, PREVENTING POSTPARTUM DEPRESSION - A REAL-WORLD EXAMINATION OF A PREDICTIVE TEST FOR PPD". The grant has a performance period from September 30, 2024 to September 29, 2028. The project aims to transform health care for service...
This $306,971 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research into the "Neurovascular Mechanisms of Depression and Implications in Cardiovascular Health" at the University of Arizona. The 2-year grant, which commenced on April 1, 2024, funds basic and applied research activities by the University to investigate the relationships between neurological, vascular, and psychological...
This $3,800,334 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund The Regents of the University of Colorado to conduct research to improve maternal mental health in military-affiliated pregnant women through the effectiveness of a smart bassinet intervention. The project will run from June 2024 to June 2028 and aims to develop and evaluate an innovative technological solution to address mental health...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $3,141,404.00 to Rush University Medical Center to conduct a randomized controlled trial evaluating the efficacy of combined cognitive processing therapy and stellate ganglion blocks for treating post-traumatic stress disorder (PTSD). The study will take place over a period of approximately 4 years, from September 1, 2024 to August 31, 2028. The research...
This Project Grant award from the Defense Health Agency provides $1,077,570.00 to New York University (NYU) to develop a state-of-the-art microbur-driven non-absorbable epithelial SERT antagonist to treat anxiety and depression in military members and the general public. The award is funded under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for service members and the public through...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 (Child Health and Human Development Extramural Research), will provide $689,409 to the University of Illinois to conduct a clinical translational study on the role of the microbiota-gut-brain axis (MGBA) in perinatal depression (PND). The research aims to determine causal influences of MGBA signatures on depressive symptom severity during pregnancy and postpartum,...
This Project Grant award in the amount of $308,000.00 was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to the University of Rochester. The grant is funding a research project to investigate "INVESTIGATING MICROGLIAL REMODELING OF NEURAL CIRCUITS IN PREGNANCY" over a 2-year period from November 15, 2023 to November 14, 2025. The project aims to advance scientific understanding of the role of microglia, a type of immune...
The Defense Health Agency awarded a $1,398,689 Project Grant to the University of Illinois under the Military Medical Research and Development program (CFDA 12.420) to support research on "Pharmacologic Downregulation of SOX2 to Enhance Efficacy of Anti-AR Therapies in Prostate Cancer". The project aims to investigate methods for improving the effectiveness of anti-androgen therapies for prostate cancer through modulating the SOX2 protein. The award will fund this 3-year research...